Prevalence of drug interactions in hospital healthcare

International Journal of Clinical Pharmacy

Volumn 34, Issue 6, 2012, Pages 807-817

  Espinosa Bosch, María ^a   Santos Ramos, Bernardo ^a   Gil Navarro, María Victoria ^a   Santos Rubio, María Dolores ^a   Marín Gil, Roberto ^a   Villacorta Linaza, Paloma ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Drug interactions; Hospital; Prevalence

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMIODARONE; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; COUMARIN ANTICOAGULANT; CYCLOSPORIN; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUCONAZOLE; HEPARIN; LOOP DIURETIC AGENT; PARACETAMOL; PHENYTOIN; POTASSIUM; PROCHLORPERAZINE; SPIRONOLACTONE; WARFARIN;

CLINICAL PHARMACY; ELDERLY CARE; EMERGENCY WARD; HEALTH CARE QUALITY; HEART DISEASE; HIGH RISK POPULATION; HOSPITAL CARE; HUMAN; MEDICATION ERROR; OUTPATIENT DEPARTMENT; PHARMACEUTICAL CARE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AGE FACTORS; CLINICAL PHARMACY INFORMATION SYSTEMS; COMORBIDITY; DRUG INTERACTIONS; DRUG THERAPY; HUMANS; MEDICATION ERRORS; PHARMACY SERVICE, HOSPITAL; POLYPHARMACY; RISK FACTORS;

EID: 84872191668     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9697-0     Document Type: Review

References (56)

1. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370:185-91. (Pubitemid 47042897)
2. Zopf Y, Rabe C, Neubert A, Hahn A, Dormann D. Risk factors associated with adverse drug reactions following hospital admission: A prospective analysis of 907 patients in two German university hospitals. Drug Saf. 2008;31:789-98.
3. Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2009;18:639-45.
4. Rodri'guez-Terol A, Caraballo MO, Palma D, Santos-Ramos D, Molina T, Desongles T, Aguilar A. Calidad estructural de las bases de datos de interacciones. Farm Hosp. 2009;33:134-96.
5. Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Drug related admissions to an Australian hospital. J Clin Pharm Ther. 1994;19:341-7. (Pubitemid 24369404)
6. Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54:959-63. (Pubitemid 29104418)
7. Peyriere H, Cassan S, Floutard E, Riviere S, Blayac JP, Hillaire-Buys D, et al. Adverse drug events associated with hospital admission. Ann Pharmacother. 2003;37:5-11. (Pubitemid 36068590)
8. Egger T, Dormann H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, et al. Identification of adverse drug reactions in geriatric inpatients using a computerized drug database. Drugs Aging. 2003;20:769-76. (Pubitemid 36995253)
9. Depont F, Vargas F, Dutronc H, Giauque E, Ragnaud JM, Galperine T, et al. Drug-drug interactions with systemic antifungals in clinical practice. Pharmacoepidemiol Drug Saf. 2007;16:1227-33. (Pubitemid 350120648)
10. Herr RD, Caravati EM, Tyler LS, Iorg E, Linscott MS. Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med. 1992;21:1331-6.
11. Crespo CA, Guerrero E, Sanmarti'n P. Interacciones entre medicamentos: Deteccio'n precoz mediante un sistema computerizado. Farm Hosp. 1992;16:38-44.
12. Braverman SE, Howard RS, Bryant PR, Belandres PV. Potential drug interactions in a physical medicine and rehabilitation clinic. Am J Phys Med Rehabil. 1996;75:44-9. (Pubitemid 26081532)
13. Sierra P, Castillo J, Gomez M, Sorribes V, Monterde J, Castano J. Interacciones potenciales y reales en pacientes cri'ticos. Rev Esp Anestesiol Reanim. 1997;44:383-7. (Pubitemid 28057012)
14. Kohler GI, Bode-Boger SM, Busse R, Hoopmann M, Welte T, Boger RH. Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000;38:504-13.
15. Langdorf MI, Fox JC, Marwah RS, Montague BJ, Hart MM. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med. 2000;7:1321-9.
16. Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38:666-71. (Pubitemid 33131567)
17. Mur Lalaguna MA, Cobos Campos R, Hurtado Gomez MF, Marwah RS. Estudio de las interacciones entre fa'rmacos antirretrovirales y tratamiento concominante. Farm Hosp. 2003;27: 84-92. (Pubitemid 36605940)
18. Miyasaka LS, Atallah AN. Risk of drug interaction: Combination of antidepressants and other drugs. Rev Saude Publica. 2003; 37:212-5.
19. Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003;58:773-8. (Pubitemid 36399235)
20. Wilcock A, Thomas J, Frisby J, Webster M, Keeley V, Finn G, et al. Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: A multicentre audit. Br J Clin Pharmacol. 2005;60:326-9. (Pubitemid 41224142)
21. Saltvedt I, Spigset O, Ruths S, Fayers P, Kaasa S, Sletvold O. Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: A randomized study. Eur J Clin Pharmacol. 2005;61:921-8. (Pubitemid 41803703)
22. Yusuff KB, Balogun O. Physicians' prescribing of anti-hypertensive combinations in a tertiary care setting in southwestern Nigeria. J Pharm Pharm Sci. 2005;8:235-42. (Pubitemid 41519137)
23. Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol. 2005;56:286-90. (Pubitemid 40941799)
24. Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalized patients-frequent but mostly clinically insignificant. Eur J Clin Pharmacol. 2005;61:675-81.
25. Lo'pez Va'zquez P, Rodri'guez Moreno C, Dura'n Parrondo C, Tato Herrero F, Rodri'guez Lo'pez I, Lado Lado FL. Interacciones entre medicamentos prescritos al alta en un Servicio de Medicina Interna. An Med Intern. 2005;22:69-75. (Pubitemid 40488453)
26. Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf. 2006;29:79-90. (Pubitemid 43213897)
27. Hassan FA, Taylor D, Leow F, Doolan G, Knott J. Potential interactions between drugs taken by emergency department patients of an Australian hospital. J Pharm Pract Res. 2006;4: 266-70. (Pubitemid 46166325)
28. Hastings SN, Sloane RJ, Goldberg KC, Oddone EZ, Schmader KE. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic. J Am Geriatr Soc. 2007;55:1339-48. (Pubitemid 47329242)
29. Miller CD, El-Kholi R, Faragon JJ, Lodise TP. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy. 2007;27:1379-86. (Pubitemid 47530444)
30. Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007;99: 592-600. (Pubitemid 47073540)
31. Peral AJ, Lertxundi EU, Martinez Bengoechea MJ, Mora AO, Franco LE, Gabilondo Z. Evaluacio'n prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicacio ́n informa'tica. Farm Hosp. 2007;31:93-100. (Pubitemid 47013962)
32. Radosevic N, Gantumur M, Vlahovic-Palcevski V. Potentially inappropriate prescribing to hospitalised patients. Pharmacoepidemiol Drug Saf. 2008;17:733-7.
33. Blix HS, Viktil KK, Moger TA, Reikvam A. Identification of drug interactions in hospitals-computerized screening vs. bedside recording. J Clin Pharm Ther. 2008;33:131-9. (Pubitemid 351341404)
34. Riechelmann RP, Zimmermann C, Chin SN, Wang L, O'Carroll A, Zarinehbaf S, et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage. 2008;35:535-43.
35. Marti'n I, Feal B, Pineiro MJ, Cuna B. Deteccio'n de interacciones medicamento-medicamento en un sistema de dispensacio'n dosisdi ́a. Farm Hosp. 1992;16:198-202.
36. Gonzalez R, Gomez M, Monterde J. Deteccio'n "en proceso" de interacciones farmacolo'gicas. Farm Clin. 1993;10:488-92.
37. Wiltink EH. Medication control in hospitals: A practical approach to the problem of drug-drug interactions. Pharm World Sci. 1998;20:173-7. (Pubitemid 28393872)
38. Gaddis GM, Holt TR, Woods M. Drug interactions in at-risk emergency department patients. Acad Emerg Med. 2002;9: 1162-7. (Pubitemid 35291545)
39. Garci'a Batllé C, Pla Poblador R. Revisio'n de interacciones farmacolo'gicas en un Hospital General. Farm Hosp. 2002;26: 110-8. (Pubitemid 34533214)
40. Gaeta TJ, Fiorini M, Ender K, Bove J, Diaz J. Potential drug-drug interactions in elderly patients presenting with syncope. J Emerg Med. 2002;22:159-62. (Pubitemid 34157258)
41. Ledwidge M, Travers B, Ryder M, Ryan E, McDonald K. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and druginteractions. Eur J Heart Fail. 2004;6:235-43. (Pubitemid 38249368)
42. Yu DT, Peterson JF, Seger DL, Gerth WC, Bates DW. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf. 2005;14:755-67. (Pubitemid 41684468)
43. Vonbach P, Dubied A, Beer JH, Krahenbuhl S. Recognition and management of potential drug-drug interactions in patients on internal medicine wards. Eur J Clin Pharmacol. 2007;63:1075-83. (Pubitemid 47561805)
44. Martinbiancho J, Zuckermann J, Dos Santos L, Silva MM. Profile of drug interactions in hospitalized children. Pharm Pract. 2007;5:157-61. (Pubitemid 350303091)
45. Mok S, Minson Q. Drug-related problems in hospitalized patients with HIV infection. Am J Health Syst Pharm. 2008;65:55-9.
46. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med. 1990;112:61-4. (Pubitemid 20026369)
47. Gronroos PE, Irjala KM, Huupponen RK, Scheinin H, Forsstrom J, Forsstrom JJ. A medication database-a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol. 1997;53:13-7. (Pubitemid 27430024)
48. Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation. 2001;49: 283-8. (Pubitemid 32588706)
49. Davies SJ, Eayrs S, Pratt P, Lennard MS. Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards. Br J Clin Pharmacol. 2004;57:464-72. (Pubitemid 38519652)
50. Samoy LJ, Zed PJ, Wilbur K, Balen RM, bu-Laban RB, Roberts M. Drugrelated hospitalizations in a tertiary care internal medicine service of a Canadian hospital: A prospective study. Pharmacotherapy. 2006;26:1578-86. (Pubitemid 44704470)
51. Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9:427-33. (Pubitemid 46630111)
52. Jankel CA, Speedie SM. Detecting drug interactions: A review of the literature. DICP. 1990;24:982-9. (Pubitemid 20307253)
53. Lalloo UG. Efavirenz and nevirapine interactions with rifampicin: Resolving the dilemmas? Clin Infect Dis. 2009;48:1760-2.
54. Soriano V, Geretti AM, Perno CF, Fatkenheuer G, Pillay D, Reynes J, et al. Optimal use of maraviroc in clinical practice. AIDS. 2008;22:2231-40.
55. Hellinger FJ, Encinosa WE. Inappropriate drug combinations among privately insured patients with HIV disease. Med Care. 2005;43(9 Suppl):III53-62. (Pubitemid 41329371)
56. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalizations and emergency department visits due to drug-drug interactions: A literature review. Pharmacoepidemiol Drug Saf. 2007;16:641-51. (Pubitemid 47039530)